Abstract:Hypoxia in a solid tumor microenvironment (TME) can lead to the overexpression of hypoxia-inducible factor-1α (HIF-1α), which correlates to tumor metastasis. Reactive oxygen species (ROS) induced tumor cell apoptosis is becoming a promising method in tumor treatment. Currently, the ROS generating systems, e.g., photodynamic treatment and sonodynamic treatment, highly depend on oxygen (O2) in the tumor microenvironment (TME). However, the level of O2 in TME is too low to produce enough ROS. Herein, we developed an ultrasmall DSPE-PEG2000 coated barium titanate nanoparticle (P-BTO) for tumor treatment based on ultrasound triggered piezocatalysis and water splitting. Interestingly, irradiated by ultrasound, the surface of ultasmall P-BTO nanoparticles produced imbalance charges, which induced a cascade of redox reaction processes to simultaneously generate ROS and O2, the latter one was hardly generated in large-sized barium titanate nanoparticles. The as-synthesized P-BTO reached the highest accumulation in the tumor site at 4 h after intravenous injection. The results showed that the produced O2 significantly alleviated the hypoxia of TME to down-regulate the expression of HIF-1α, and the produced ROS can efficiently kill tumor cells. Moreover, the tumor metastasis was also inhibited, providing a different way to treat triple-negative breast cancer, which was easily metastatic and lacked effective treatments in the clinic.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c00616?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c00616</a>.Additional TEM figures for further characterization of 200 nm BTO, BTO nanowires, EDS spectrum of P-BTO, and XPS spectrum of Ba 3d, C 1s, O 1s, and Ti 2p (Supplementary Figure S1); the solution appearance under different conditions (Supplementary Figure S2); fluorescence images of [Ru(dpp)3]Cl2 in 4T1 cells after different treatments with (a) control, (b) US + 200 nm BTO, and (c) US + BTO nanowire (Supplementary Figure S3); cytotoxicity profiles of control group, P-BTO group, US group, and US+P-BTO group under normoxic conditions (Supplementary Figure S4); hemolysis rate of RBCs incubated with P-BTO and complete blood count of health female Balb/c mice at different time points post injection of P-BTO (Supplementary Figure S5); biodistribution of Ba in organs and tumor at 4 h after intravenous injection of P-BTO (Supplementary Figure S6); tumor weight of female Balb/c mice after US+P-BTO treatment (Supplementary Figures S7); histological analysis of major organs by H&E staining after different treatments (Supplementary Figure S8); comparison of the P-BTO with existing procedures (Supplementary Table S1); acronyms and corresponding full names (Supplementary Table S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c00616/suppl_file/nn1c00616_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A continuously efficient O2-supplying strategy for long-term modulation of hypoxic tumor microenvironment to enhance long-acting radionuclides internal therapy

Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.

Oxygen-Independent Radiodynamic Therapy: Radiation-Boosted Chemodynamics for Reprogramming the Tumor Immune Environment and Enhancing Antitumor Immune Response

Biomimetic Nanoreactor of Catalase and Nitric Oxide Enhance Peroxynitrite Generation for Radiosensitization

A Mitochondria-targeted Multifunctional Nanoplatform Combining Carbon Monoxide Delivery with O 2 -independent Free Radical Burst under 1064 nm Light Irradiation for Efficient Hypoxic Tumor Therapy

A Catalase‐Like Metal‐Organic Framework Nanohybrid for O 2 ‐evolving Synergistic Chemoradiotherapy

Two-stage Oxygen Delivery for Enhanced Radiotherapy by Perfluorocarbon Nanoparticles

Multistage‐Responsive Dual‐Enzyme Nanocascades for Synergistic Radiosensitization‐Starvation Cancer Therapy

Graphdiyne-templated palladium-nanoparticle assembly as a robust oxygen generator to attenuate tumor hypoxia

Nanozyme with Robust Catalase Activity by Multiple Mechanisms and Its Application for Hypoxic Tumor Treatment

Catalase Nanocrystals Loaded with Methylene Blue as Oxygen Self‐Supplied, Imaging‐Guided Platform for Photodynamic Therapy of Hypoxic Tumors

An NIR-II Photothermally Triggered "Oxygen Bomb" for Hypoxic Tumor Programmed Cascade Therapy

Integrated energy conversion units in nanoscale frameworks induce sustained generation and amplified lethality of singlet oxygen in oxidative therapy of tumor

Cascaded Nanozyme with In‐Situ Enhanced Photothermal Capacity for Tumor‐Specific and Self‐Replenishing Cancer Therapy

Persistent Regulation of Tumor Hypoxia Microenvironment via a Bioinspired Pt‐Based Oxygen Nanogenerator for Multimodal Imaging‐Guided Synergistic Phototherapy

Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies

Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors

An Oxygen Self-Evolving, Multistage Delivery System for Deeply Located Hypoxic Tumor Treatment

Ultrasmall Barium Titanate Nanoparticles for Highly Efficient Hypoxic Tumor Therapy via Ultrasound Triggered Piezocatalysis and Water Splitting

Boosting Chemodynamic Therapy via a Synergy of Hypothermal Ablation and Oxidation Resistance Reduction

Glucose-responsive enzymatic biomimetic nanodots for H2O2 self-supplied catalytic photothermal/chemodynamic anticancer therapy